
The role of viral infections in causing exacerbations of Multiple Sclerosis is well known. Potential safety concerns about using immunosuppressive MS disease modifying therapies (DMTs) during the COVID-19 pandemic are overstated, according to most MS experts. A new large community-based study found that 57% of people with MS and COVID-19 experience an MS exacerbation during… Read more »
Recent Comments